Burchardt U
Z Gesamte Inn Med. 1983 Nov 1;38(21):565-70.
In a survey the present possibilities are outlined to get knowledge about diseases of inner organs with the help of enzyme determinations in the urine. Here it is remarkable that changes of the enzyme excretion appear not only in renal disease with acute renal failure, pyelonephritis, glomerulonephritis, renal infarction and nephroptosis but are also to be observed in primarily extrarenal diseases such as diabetes mellitus, hyperthyroidism, thesaurismoses, myocardial infarction, hypertension, acute pancreatitis, epidemic hepatitis, liver cirrhosis, obstructive jaundice and rheumatoid arthritis. The causes of the changes of enzyme excretions are various. Since enzymes of different origin and localisation behave themselves variably, the simultaneous determination of a brush border marker (e.g. alanine aminopeptidase), a lysosomal enzyme (e.g. beta-glucuronidase or N-acetyl glucosaminidase) and a low molecular enzyme (e.g. lysozyme) is of use for the recognition of renal alterations. By the control of activities of urinary enzymes it is possible to get without risk informations about pathobiochemical processes in the kidney which are not to be gained by means of other methods.
在一项调查中概述了目前借助尿液中的酶测定来了解内脏疾病的可能性。值得注意的是,酶排泄的变化不仅出现在患有急性肾衰竭、肾盂肾炎、肾小球肾炎、肾梗死和肾下垂的肾脏疾病中,而且在原发性肾外疾病如糖尿病、甲状腺功能亢进、贮积症、心肌梗死、高血压、急性胰腺炎、流行性肝炎、肝硬化、梗阻性黄疸和类风湿性关节炎中也可观察到。酶排泄变化的原因多种多样。由于不同来源和定位的酶表现各异,同时测定一种刷状缘标记物(如丙氨酸氨基肽酶)、一种溶酶体酶(如β-葡萄糖醛酸酶或N-乙酰葡糖胺酶)和一种低分子酶(如溶菌酶)有助于识别肾脏改变。通过控制尿酶活性,可以无风险地获得有关肾脏病理生化过程的信息,而这些信息是通过其他方法无法获得的。